Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Michael Van Waes"'
Autor:
Charles M. Thompson, Scott P. Hennelly, Jing Yuan, James M. Bullard, Michael Van Waes, Wendy T. Grace, Bucklin Dj, Walter E. Hill, Gregory W. Muth
This chapter deals with the cleavage of RNA as an approach to the study of ribosome structure. Chemical nucleases, such as EDTA-Fe(II) and phenanthroline-Cu(II), have been widely used to cleave both RNA and DNA, and more recently, they have been used
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36ac70de0aeaf21f002c9b4193cf883c
https://doi.org/10.1128/9781555818142.ch22
https://doi.org/10.1128/9781555818142.ch22
Publikováno v:
Developmental Genetics. 14:137-147
The present study was undertaken to examine the role of heat shock response in the development of tolerance and cross-tolerance in an in vivo murine model of teratogen-induced neural tube defects. The experimental paradigm designed to address this qu
Publikováno v:
Journal of molecular biology. 252(5)
tRNAPhetranscribed in a T7 RNA polymerase system has been modified in such a way that 4-thiouridines have randomly replaced unmodified uridines. These 4-thiouridines serve as sites for conjugation of the cleavage reagent 5-iodoacetamido-1, 10-phenant
Publikováno v:
Epilepsia. 35(1)
Summary: To test the hypothesis that the cytochrome P-450-inhibiting antiepileptic drug (AED) Stiripentol (STP) can reduce the incidence of phenytoin (PHT) induced congenital malformations, we chronically administered the AEDs to three inbred mouse s
Publikováno v:
Reproductive toxicology (Elmsford, N.Y.). 7(5)
Differences in the patterns of congenital malformations observed in three inbred mouse strains (SWV, LM/Bc, and C57BL/6J) were compared following exposure to phenytoin monotherapy and a polytherapeutic regimen of phenytoin and stiripentol. Treatment
Autor:
Janee Gelineau-van Waes, Michael Van Waes, J. Maddox, Lynette M. Smith, James D. Eudy, Justin Wilberding, Linda K. Bauer, Richard H. Finnell
Publikováno v:
BMC Genomics
BMC Genomics, Vol 9, Iss 1, p 156 (2008)
BMC Genomics, Vol 9, Iss 1, p 156 (2008)
Background The reduced folate carrier (RFC1) is an integral membrane protein and facilitative anion exchanger that mediates delivery of 5-methyltetrahydrofolate into mammalian cells. Adequate maternal-fetal transport of folate is necessary for normal